CSF2 and neoplasm: It is a modified live-attenuated herpes simplex virus type 1 designed to promote an anti-tumor response by selectively replicating tumor cells and producing a granulocyte–macrophage colony-stimulating factor (GM-CSF) to stimulate systemic anti-tumor immunity [185,186].